TREA

79284012 - TRB

Follow

Information

  • Trademark
  • 79284012
  • Serial Number
    79284012
  • Registration Number
    6258760
  • Filing Date
    March 11, 2020
    4 years ago
  • Registration Date
    February 02, 2021
    3 years ago
  • Transaction Date
    January 10, 2025
    14 days ago
  • Status Date
    February 02, 2021
    3 years ago
  • Published for Opposition Date
    November 17, 2020
    4 years ago
  • Location Date
    February 02, 2021
    3 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    LAM, HAI-LY
  • Attorney Name
    Andrew M. Smith
    Law Office Assigned Location Code
    N10
  • Owners
Information
Mark Drawing Code
3
Mark Identification
TRB
Case File Statements
  • DM0000: The mark consists of a circular design outlined in blue containing zig-zag bands in blue followed to the right by the letters "TRB" in blue. The color white represents background, outlining, shading, and/or transparent areas and is not part of the mark.
  • GS0051: pharmaceuticals, namely, anti-neurodegenerative, anti-neurotrophic, anti-antineurotoxic, neuroprotective and neurorestorative effect agents; pharmaceuticals, namely, immunopharmaceuticals; medical and veterinary preparations, namely, preparations for use in treating joint disease in horses, and antioxidants; pharmaceutical and medicinal preparations and substances for treating and preventing ophthalmic, ocular, neurological, metabolic, dermatological, arthritic, cognitive, or sexual dysfunction-related conditions, disorders or diseases; pharmaceutical and medicinal preparations and substances for treating and preventing joint, ligament, tendon, cartilage, bone, damaged skin or tissue-related conditions, disorders or diseases; pharmaceutical and medicinal preparations and substances for the treatment of central or peripheral nervous system-related, spinal cord-related, or early stages of traumatic or acute vascular injury-related disorders and diseases; pharmaceutical and medicinal preparations and substances for the treatment of pain, inflammation, physical lesions, and wounds; analgesics; anti-inflammatories; medicines for the treatment of keratitis, Sjögren's syndrome or primary dry eye syndrome; medicines for use as surgical aid during cataract surgery procedures; medicines for the treatment of osteoarthritis and rheumatoid arthritis; medicines for the prevention of osteoporosis; medicines for the treatment of musculo-skeletal conditions, disorders or diseases; medicines for the treatment of tendinopathy; medicines for joint recovery after arthroscopy; medicines to help assist with the regeneration of ligament and tendon fibers; medicines for the treatment of immune system related diseases and disorders; medicines for the treatment of blepharitis, glaucoma, and degenerative eye pathologies; pharmaceutical drugs for the treatment of keratitis, Sjögren's syndrome or primary dry eye syndrome; pharmaceutical drugs for use as surgical aid during cataract surgery procedures; pharmaceutical drugs for the treatment of osteoarthritis and rheumatoid arthritis; pharmaceutical drugs for the prevention of osteoporosis; pharmaceutical drugs for the treatment of musculo-skeletal conditions, disorders or diseases; pharmaceutical drugs for the treatment of tendinopathy; pharmaceutical drugs for joint recovery after arthroscopy; pharmaceutical drugs to help assist with the regeneration of ligament and tendon fibers; pharmaceutical drugs for the treatment of immune system related diseases and disorders; pharmaceutical drugs for the treatment of blepharitis, glaucoma, and degenerative eye pathologies; therapeutic drugs for the treatment of keratitis, Sjögren's syndrome or primary dry eye syndrome; therapeutic drugs for use as surgical aid during cataract surgery procedures; therapeutic drugs for the treatment of osteoarthritis and rheumatoid arthritis; therapeutic drugs for the prevention of osteoporosis; therapeutic drugs for the treatment of musculo-skeletal conditions, disorders or diseases; therapeutic drugs for the treatment of tendinopathy; therapeutic drugs for joint recovery after arthroscopy; therapeutic drugs to help assist with the regeneration of ligament and tendon fibers; therapeutic drugs for the treatment of immune system related diseases and disorders, and therapeutic agents for the treatment of keratitis, Sjögren's syndrome or primary dry eye syndrome; therapeutic agents for use as surgical aid during cataract surgery procedures; therapeutic agents for the treatment of osteoarthritis and rheumatoid arthritis; therapeutic agents for the prevention of osteoporosis; therapeutic agents for the treatment of musculo-skeletal conditions, disorders or diseases; therapeutic agents for the treatment of tendinopathy; therapeutic agents for joint recovery after arthroscopy; therapeutic agents to help assist with the regeneration of ligament and tendon fibers; therapeutic agents for the treatment of immune system related diseases and disorders; transdermal patches featuring vitamins for increasing energy for medical use; biological cartilage, bone or skin tissue intended for subsequent implantation; biological preparations for medical or veterinary use, namely, for the treatment of infectious diseases; sanitary preparations for medical purposes; dietetic food and substances in the nature of food supplements and vitamins supplements all adapted for medical or veterinary use; food for babies; dietary supplements for humans and animals; meal replacements, namely, meal replacement bars adapted for medical use and meal replacement beverages adapted for medical use, and dietetic beverages adapted for medical and veterinary use; materials for dressings, namely, dressings for wounds, burns or surgery, adhesive bandages, gauze for dressings, pledgets; disinfectants
  • CC0000: The color(s) blue is/are claimed as a feature of the mark.
Case File Event Statements
  • 5/29/2020 - 4 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 4/23/2020 - 4 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 4/27/2020 - 4 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 5/1/2020 - 4 years ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 5/21/2020 - 4 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 5/28/2020 - 4 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 6/30/2020 - 4 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 6/30/2020 - 4 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 7/18/2020 - 4 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 10/7/2020 - 4 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 10/7/2020 - 4 years ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 10/8/2020 - 4 years ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 10/28/2020 - 4 years ago
    14 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 10/13/2020 - 4 years ago
    13 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 11/17/2020 - 4 years ago
    16 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 11/17/2020 - 4 years ago
    15 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 2/2/2021 - 3 years ago
    17 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 5/2/2021 - 3 years ago
    18 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 5/5/2021 - 3 years ago
    19 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 2/26/2023 - a year ago
    25 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 5/5/2021 - 3 years ago
    20 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 5/18/2021 - 3 years ago
    23 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 5/18/2021 - 3 years ago
    21 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 5/18/2021 - 3 years ago
    22 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 5/30/2021 - 3 years ago
    24 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 2/26/2023 - a year ago
    26 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 2/26/2023 - a year ago
    27 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 6/9/2024 - 7 months ago
    28 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH
  • 6/30/2024 - 6 months ago
    29 - CORRECTION TRANSACTION RECEIVED FROM IB Type: CRCV
  • 9/18/2024 - 4 months ago
    30 - CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED Type: CORR